Keith A Kucinski - Net Worth and Insider Trading
Keith A Kucinski Net Worth
The estimated net worth of Keith A Kucinski is at least $15,593 dollars as of 2024-05-22. Keith A Kucinski is the CFO of Matinas BioPharma Holdings Inc and owns about 94,500 shares of Matinas BioPharma Holdings Inc (MTNB) stock worth over $15,593. Details can be seen in Keith A Kucinski's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Keith A Kucinski has not made any transactions after 2019-11-25 and currently still holds the listed stock(s).
Transaction Summary of Keith A Kucinski
Keith A Kucinski Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Keith A Kucinski owns 1 companies in total, including Matinas BioPharma Holdings Inc (MTNB) .
Click here to see the complete history of Keith A Kucinski’s form 4 insider trades.
Insider Ownership Summary of Keith A Kucinski
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MTNB | Matinas BioPharma Holdings Inc | 2019-11-25 | Chief Financial Officer |
Keith A Kucinski Latest Holdings Summary
Keith A Kucinski currently owns a total of 1 stock. Keith A Kucinski owns 94,500 shares of Matinas BioPharma Holdings Inc (MTNB) as of November 25, 2019, with a value of $15,593.
Latest Holdings of Keith A Kucinski
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MTNB | Matinas BioPharma Holdings Inc | 2019-11-25 | 94,500 | 0.17 | 15,593 |
Holding Weightings of Keith A Kucinski
Keith A Kucinski Form 4 Trading Tracker
According to the SEC Form 4 filings, Keith A Kucinski has made a total of 1 transactions in Matinas BioPharma Holdings Inc (MTNB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Matinas BioPharma Holdings Inc is the acquisition of 94,500 shares on November 25, 2019, which cost Keith A Kucinski around $115,290.
Insider Trading History of Keith A Kucinski
- 1
Keith A Kucinski Trading Performance
GuruFocus tracks the stock performance after each of Keith A Kucinski's buying transactions within different timeframes. To be detailed, the average return of stocks after 1 year bought by Keith A Kucinski is -20.16%. GuruFocus also compares Keith A Kucinski's trading performance to market benchmark return within the same time period. The performance of stocks bought by Keith A Kucinski within 1 year outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Keith A Kucinski's insider trading performs compared to the benchmark.
Performance of Keith A Kucinski
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 57.52 | | | | | |
| Relative Return to S&P 500(%) | 54.66 | | | | | |
Keith A Kucinski Ownership Network
Keith A Kucinski Owned Company Details
What does Matinas BioPharma Holdings Inc do?
Who are the key executives at Matinas BioPharma Holdings Inc?
Keith A Kucinski is the Chief Financial Officer of Matinas BioPharma Holdings Inc. Other key executives at Matinas BioPharma Holdings Inc include Chief Technology Officer Liu Hui , Chief Business Officer Thomas Hoover , and director & Chief Executive Officer Jerome D Jabbour .
Matinas BioPharma Holdings Inc (MTNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Matinas BioPharma Holdings Inc (MTNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Matinas BioPharma Holdings Inc (MTNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Matinas BioPharma Holdings Inc (MTNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Matinas BioPharma Holdings Inc Insider Transactions
Keith A Kucinski Mailing Address
Above is the net worth, insider trading, and ownership report for Keith A Kucinski. You might contact Keith A Kucinski via mailing address: C/o Matinas Biopharma Holdings Inc., 1545 Rt. 206 South, Suite 302, Bedminster Nj 07921.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
